Healthcare startup ecosystem
We track 42 organisations in this sector across 6+ countries.
Showing 21–40 of 42 Healthcare
Countries in this sector
Sectors alongside this one
Healthcare results
-
Liz Theophille
Chief Digital and Information Officer at Sandoz, a global generics and biosimilars company, with a career leading large-scale digital transformation across pharmaceutical and technology organizations. She is an announced keynote speaker at the 2026 #wetechtogether Conference in Zurich.
-
Marco Neves
President and CEO of Portugal Ventures for the 2025–2027 term, leading Portugal's state-backed early-stage venture firm within the Banco Português de Fomento group. He oversees the firm's pre-seed to Series A investments across technology, health and tourism startups nationwide.
-
Michał Rokosz
Partner at Inovo Venture Partners, one of Poland's leading early-stage funds. Before venture capital he was COO at Booksy and held roles at foodpanda and Rocket Internet, giving him operational depth in marketplaces and e-commerce; his investment focus includes B2B and healthcare.
-
Mindsmiths
Mindsmiths is a Zagreb-based AI company developing an Autonomous Support System (ASS) platform that enables digital products to make independent decisions and engage users proactively. The platform has been deployed in healthcare (chronic patient support) and banking (financial advisory). Mindsmiths raised EUR 1.2 million in 2021 from Feelsgood Capital, with CEO Mislav Malenica also serving as president of the Croatian AI Association.
-
mRNA-Based Therapeutics Summit Europe 2026
Dedicated summit in Berlin for mRNA-based therapeutics, bringing together pharma executives, biotech researchers, and clinical development leaders. Covers R&D breakthroughs, manufacturing scale-up, and regulatory pathways for mRNA technologies in Europe. Relevant for biotech startups working on next-generation mRNA platforms and delivery systems.
-
Niklas Blomberg
Niklas Blomberg is Executive Director of the Innovative Health Initiative (IHI), a major public-private partnership joint undertaking established by the European Union and EFPIA with approximately €2 billion in funding for health research and innovation. He oversees one of Europe's most significant health R&D programmes, bridging academia, industry, regulators, and patient organisations. He is a key figure in European health innovation policy and ecosystem building.
-
Novo Holdings
Novo Holdings is the investment arm of the Novo Nordisk Foundation and the largest life science investor in Denmark. It backs biotech, medtech, and health innovation across seed, venture, and growth stages while also managing the foundation's long term ownership in Novo Nordisk and Novozymes. The firm provides patient capital, deep scientific expertise, and global networks for founders building therapies, diagnostics, and industrial biotech solutions. Novo Holdings is a cornerstone of the Danish life science ecosystem.
-
Owkin
Owkin is a Paris-based AI biotech founded in 2016 that applies machine learning and federated learning across hospital and pharmaceutical datasets to discover drug targets, develop diagnostics and de-risk clinical trials. It partners with pharmaceutical companies including Sanofi and Bristol Myers Squibb, reached unicorn status, and has more recently launched agentic AI tools for biopharma research.
-
Predicting Health
Predicting Health develops AI-based clinical risk prediction tools that analyze patient data to support early intervention and improve care quality. The company is a spin-off from the KAGes Data Science Team in Graz and operates in the same category as platforms like PIPRA.
-
Prosperus Invest
Prosperus Invest was founded in 2010 in Zagreb as a growth equity and private equity fund manager focused on expansion-stage SMEs across Croatia and the broader Adriatic region. Led by Joško Miliša and Partner Luka Orešković, the firm has grown assets under management approximately 4× to around €200 million. Its flagship Prosperus Growth fund (first close ~€50 million, backed by EIF and HBOR under the CROGIP program) commits at least 75% to Croatian SMEs in IT, hospitality, renewables, healthcare, and publishing, with notable investments including IntechOpen (scientific open-access publishing, Rijeka) and Neos (data analytics and cloud IT services).
-
RobotDreams
RobotDreams is a Graz-based healthtech startup founded in 2022 that develops AI diagnostics software analyzing blood biomarker data to accelerate detection of acute conditions such as acute coronary syndrome. The platform aims to reduce diagnostic turnaround times in emergency departments by applying machine learning to in-vitro diagnostics results, helping clinicians make faster triage decisions. RobotDreams competes in the growing AI-enabled clinical diagnostics space and targets hospitals, laboratories, and emergency-care providers across Europe.
-
Roman Pałac
Business Angel Debutant of the Year (2021) and former CEO of Gemini Polska as well as former president of PZU Życie. Roman transitioned from top-level corporate leadership into startup investing with a focus on business transformation and commercial execution. He primarily backs startups in healthcare, insurance, and business transformation, bringing operator-level support in sales strategy and scaling.
-
Siemens Technology Accelerator
The Siemens Technology Accelerator (STA) is a unique corporate accelerator program run by Siemens AG since 2001, aimed at spinning out non-core technologies from Siemens’ R&D into independent startups. Based in Munich, STA essentially identifies promising internal innovations (often developed at Siemens Corporate Technology labs) that don’t fit Siemens’ core business, and forms new ventures around them. STA provides seed funding, co-founding management, and access to Siemens’ infrastructure to these ventures, effectively acting as a venture builder. Over its history, the Siemens Technology Accelerator has spun out more than 12 companies across sectors like energy, industrial automation, healthcare, and materials. Notable spin-offs include MetisMotion (advanced actuators), Magazino (warehouse robotics – which STA helped early on), and Epiqo (a digital twin software). One high-profile case is Rethink Robotics GmbH: in 2020, STA helped relaunch assets of Rethink Robotics (the US cobot pioneer) in a joint venture, integrating it with Siemens technology. The typical STA project starts with identifying a tech with market potential. STA then recruits external entrepreneurs or Siemens intrapreneurs to lead the startup, develops a business plan, secures intellectual property rights (license or assign IP from Siemens to the newco), and provides initial funding (often low millions of euros). Siemens often remains a minority shareholder and provides pilot customers or manufacturing help. The time from project inception to an independent company launch is around 18–24 months. STA’s model addresses a common big-corporate problem: great inventions that don’t make it to market. By essentially incubating startups from within, Siemens both creates value from dormant IP and fosters innovation culture. Many STA spin-outs go on to raise venture capital or get acquired. For example, Ionity (an EV charging network) was seeded by Siemens’ STA and later became a major joint venture with automakers. The Siemens Technology Accelerator operates with a small specialized team and has won awards for corporate venturing. It serves as a best-practice example of how large industrial firms can proactively spin off new ventures rather than let R&D sit on a shelf. In essence, STA extends Siemens’ innovation beyond its core by unleashing startups that bring cutting-edge tech (like novel sensors, new materials, etc.) to the broader market.
-
SmartGateVC
SmartGateVC is a pre-seed and seed deep-tech venture fund co-headquartered in Yerevan and Glendale, California, founded in 2018. It focuses on AI applied to healthcare, biotech, security, and IoT, and manages a portfolio of over 40 companies. The fund is backed by Tim Draper and One Way Ventures, and the majority of its portfolio companies leverage Armenia for R&D operations.
-
SpinLab - The HHL Accelerator
Founded 2014. Six-month program for entrepreneurial teams with coworking, mentoring, and technology partners; alumni include energy and healthcare startups. Support: mentorship, workspace, partner resources. Scope: Regional (East Germany).
-
SwedenBIO
SwedenBIO is Sweden's national trade and interest organization for the life science industry, representing biotechnology, pharmaceutical, and medtech companies. Through its commercial arm SwedenBIO Service AB, it owns and produces Nordic Life Science Days (NLSDays), the largest Nordic partnering event for the life sciences sector. The organization advocates for Swedish life science competitiveness, innovation policy, and industry development at national and international levels.
-
Swiss Medtech
Swiss Medtech is the leading Swiss industry association for medical technology, representing member companies engaged in the development, manufacturing, and distribution of medical devices and in vitro diagnostics. The association advocates for regulatory and political conditions favorable to the medtech sector in Switzerland and internationally. It serves as an official industry partner of the Swiss Medtech Expo and is represented on the event's trade fair committee by its Director, Adrian Hunn.
-
Swiss Medtech Expo 2026 (September 2026)
Switzerland's leading biennial medtech trade fair for development, manufacturing and supply, organized by Messe Luzern. Around two hundred exhibitors plus a conference and innovation program draw engineers, manufacturers, suppliers and medtech startups. It is relevant to medtech founders for sourcing, partnerships and showcasing solutions in one of Switzerland's strongest industrial clusters.
-
Uni.Fund
Uni.Fund was founded in 2018 in Athens by Katerina Pramatari (Professor at Athens University of Economics and Business), Panos Lioulias, Sotiris Papantonopoulos, and Stelios Eliakis, with backing from the EquiFund programme. Fund I deployed €30M into 23 pre-seed and seed companies commercialising research from universities and research institutions across Greece and Europe. Uni.Fund II launched in 2023 with a €50M target, extending the same thesis to spin-offs and deep-tech startups at pre-seed through early Series A. Focus sectors include IoT, fintech, healthcare, robotics, and SaaS.
-
Vinnova
Vinnova is Sweden's innovation agency, responsible for fostering sustainable growth through research, development, and innovation. It distributes approximately SEK 3 billion annually in grants and co-funding to businesses, universities, research institutes, and public organizations across Sweden. Vinnova is a key government body enabling innovation in life sciences, digital health, and technology, and served as a Spotlight Panel Host at Nordic Life Science Days 2026.
